How big is Apeximmune Therapeutics Inc.'s plan?

Apeximmune Therapeutics Inc.'s plan reported $314K in assets and 5 participants for 2024.

Original filing (PDF)20250718164700NAL0002129601001

Apeximmune Therapeutics Inc.

Name: Apeximmune Therapeutics Inc. — Form 5500 (2024)
Creator: Apeximmune Therapeutics Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

401(k) retirement plan · Apeximmune Therapeutics Inc. held $314K in plan assets for 5 participants in 2024.

Active participants

Accounts w/ balance

Plan assets (EOY)

$314K

Net assets (EOY)

$314K

People on this filing

Shirley Horner signed Apeximmune Therapeutics Inc.'s 2024 Form 5500 as plan administrator.

Shirley Horner — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Apeximmune Therapeutics Inc.'s EIN is 81-3648439.

EIN 81-3648439

Plan number 001

Plan year 2024

ACK ID 20250718164700NAL0002129601001

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for Apeximmune Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

Apeximmune Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for APEXIMMUNE THERAPEUTICS INC.

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.

Plan sponsor

Name

APEXIMMUNE THERAPEUTICS INC

EIN

all filings

Address

297, BERNARDO AVE · MOUNTAIN VIEW, CA · 94043

Phone

(650) 283-4529

Industry

Wholesale Trade

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-07-18

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

HYDE Drug LLC

HYDE Drug Store 401(k) Plan

$306K · 23 participants

Friendly Pharmacy

Friendly Pharmacy 401(k) Retirement Plan

$324K · 27 participants

Algen Biotechnologies, Inc.

Algen Biotechnologies 401(k) Plan

$304K · 11 participants

Marshland Chemists Inc.

Marshland Pharmacy 401(k)

$303K · 8 participants

Emes2 Pharmaceuticals, LLC DBA RX Return Services

Emes2 Pharmaceuticals, LLC Profit Sharing Plan

$300K · 43 participants

Researching more plans? Run a Form 5500 lookup by company name, EIN, or plan name.